Obamacare? That's so last month. On capitol hill, drug prices are now the hot topic
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
WASHINGTON — Drug prices finally have lawmakers’ attention. After years in which the debate over Obamacare has dominated all health policymaking discussion on Capitol Hill, U.S. lawmakers
are increasingly turning their attention to the prices that everyday Americans pay for their prescription drugs. Less than one year ago, when the Senate health committee spent four hours
grilling Tom Price, President Trump’s nominee as secretary of health and human services, Democrats focused their most aggressive attention on his support for repealing Obamacare and for
making major changes to the Medicare and Medicaid programs, as well as his investments in an Australian biotech company. STAT+ Exclusive Story Already have an account? Log in THIS ARTICLE IS
EXCLUSIVE TO STAT+ SUBSCRIBERS UNLOCK THIS ARTICLE — PLUS IN-DEPTH ANALYSIS, NEWSLETTERS, PREMIUM EVENTS, AND NEWS ALERTS. Already have an account? Log in Individual plans Group plans View
All Plans To read the rest of this story subscribe to STAT+. Subscribe